MOMM Diagnostics
PrivateLast Round
Grant
Jan 12, 2026
Total Funding Raised
$2.34M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MOMM Diagnostics is a medical technology company that develops rapid, point-of-care diagnostic tests for the early detection of preeclampsia.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOMM Diagnostics Comparables
Compare MOMM Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lepzi | 84% | |
| Gravidas Diagnostics Inc. | 79% | |
| Modality Dx | 78% |
MOMM Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 12, 2026 | ||||
| Grant | Oct 5, 2025 | ||||
| Seed | May 31, 2022 | ||||
| Grant | May 1, 2019 |
MOMM Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Innosuisse | Seed |
| University of Basel | Seed |
| Venture Kick | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased by 50% MoM.
- Jan 22, 2026
Monthly visitors increased 217% MoM.
MOMM Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access